Results 131 to 140 of about 19,649 (222)

Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia. [PDF]

Ann Hematol
Mazzarella R, Cicconi L, Perrone S, Divona MD, Ceccolini S, Nardozza AM, Biagi A, Ottone T, Corbingi A, Panetta P, La Barbera EO, Fiori L, Romeo AA, Pacitto G, Cotroneo E, Breccia M, Voso MT, Pulsoni A.   +17 more
europepmc   +1 more source

Multimodal gene and targeted drug therapy for chronic myelogenous leukemia using BIM/MCL-1 chimeric nanoparticle: computational target analysis and therapeutic validation. [PDF]

Nano Converg
Lugin ML, Lei W, Lee RT, Chung JY, Katritsis NM, Hwang W, Fleischman AG, Han N, Kwon YJ.   +8 more
europepmc   +1 more source

Case Report: Co-existence of <i>BCR::PDGFRA</i> gene fusion and <i>PDGFRA</i> variants in myeloid neoplasm with persistent leukocytosis, large splenomegaly, and eosinophilia. [PDF]

Front Oncol
Xiao Z, Lu C, Zhang P, Han N, He X, Zhang J, Feng Y, Guan M, Ouyang L, Gao Y, Li Y.   +10 more
europepmc   +1 more source

Identification of a <i>Musashi2</i> translocation as a novel oncogene in myeloid leukemia. [PDF]

Elife
Spinler K, Hamilton M, Bajaj J, Shima Y, Diaz E, Kritzik M, Reya T.   +6 more
europepmc   +1 more source

An overview of chronic myeloid leukemia and its animal models [PDF]

, 2015

core   +1 more source

Undifferentiated Blast Crisis in Chronic Myeloid Leukaemia: <i>A rarest-of-the-rare complication in a patient on tyrosine kinase inhibitor</i>. [PDF]

Sultan Qaboos Univ Med J
Mishra P, Sharma S.
europepmc   +1 more source

Response Assessment of Generic Tyrosine Kinase Inhibitors in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: A Prospective Study from a Tertiary Care Centre in North Eastern India. [PDF]

Cureus
Choudhuri A, Bhattacharyya J, Das S, Das D, Dhameja N.   +4 more
europepmc   +1 more source

Comparison of remission rates in Egyptian patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors below the age of fifty

Family Medicine & Primary Care Review
Mohamed Said Abd Elwahab, Nermein Sayed Abd Elaziz, Nehad Mohamed Tawfeek, Moataz Fathy Mohamed, Ibrahem Ahmed Ibrahem   +4 more
doaj   +1 more source

Deactylase inhibition in myeloproliferative neoplasms [PDF]

, 2010
Sridurga Mithraprabhu, George Grigoriadis, Tiffany Khong, Andrew Spencer   +3 more
core   +1 more source

Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design. [PDF]

Circulation
Jambon-Barbara C, Suissa S, Dell'Aniello S, Hlavaty A, Cracowski JL, Chaumais MC, Humbert M, Montani D, Khouri C.   +8 more
europepmc   +1 more source